The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 17 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Carboplatin  [Clear All Filters]
Journal Article
Pectasides, D., Fountzilas G., Papaxoinis G., Pectasides E., Xiros N., Sykiotis C., et al. (2009).  Carboplatin and paclitaxel in metastatic or recurrent cervical cancer.. Int J Gynecol Cancer. 19(4), 777-81.
Katirtzoglou, N., Gkiozos I., Makrilia N., Tsaroucha E., Rapti A., Stratakos G., et al. (2010).  Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: a phase II study.. Clin Lung Cancer. 11(1), 30-5.
Maniadakis, N., Dafni U., Fragoulakis V., Grimani I., Galani E., Fragkoulidi A., et al. (2009).  Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial.. Ann Oncol. 20(2), 278-85.
Zarogoulidis, P., Petridis D., Ritzoulis C., Darwiche K., Spyratos D., Huang H., et al. (2013).  Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup.. Int J Pharm. 453(2), 480-7.
Zarogoulidis, P., Eleftheriadou E., Sapardanis I., Zarogoulidou V., Lithoxopoulou H., Kontakiotis T., et al. (2012).  Feasibility and effectiveness of inhaled carboplatin in NSCLC patients.. Invest New Drugs. 30(4), 1628-40.
Dermitzakis, E. V., Kimiskidis V. K., Lazaridis G., Alexopoulou Z., Timotheadou E., Papanikolaou A., et al. (2016).  The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer.. BMC Neurol. 16(1), 190.
Zarogoulidis, K., Eleftheriadou E., Kontakiotis T., Gerasimou G., Zarogoulidis P., Sapardanis I., et al. (2012).  Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients.. Lung Cancer. 76(1), 84-8.
Zarogoulidis, P., Petanidis S., Kioseoglou E., Domvri K., Anestakis D., & Zarogoulidis K. (2015).  MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.. Cell Signal. 27(8), 1576-88.
Gogas, H., Pectasides D., Kostopoulos I., Lianos E., Skarlos D., Papaxoinis G., et al. (2010).  Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group.. Clin Breast Cancer. 10(3), 230-7.
Briasoulis, E., Golfinopoulos V., Karina M., Papakostas P., Pavlidis N., & Fountzilas G. (2010).  Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study.. Anticancer Drugs. 21(8), 785-9.
Pectasides, D., Pectasides E., Papaxoinis G., Andreadis C., Papatsibas G., Fountzilas G., et al. (2009).  Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients.. Gynecol Oncol. 115(1), 97-101.
Tsolakidis, D., Papanikolaou A., Ktenidis K., & Pervana S. (2012).  Primary ovarian small cell carcinoma of pulmonary type with enlarged paraaortic lymph node masses: a case report and review of the literature.. Eur J Gynaecol Oncol. 33(3), 312-5.
Psyrri, A., Lee J-W., Pectasides E., Vassilakopoulou M., Kosmidis E. K., Burtness B. A., et al. (2014).  Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.. Clin Cancer Res. 20(11), 3023-32.
Bafaloukos, D., Linardou H., Aravantinos G., Papadimitriou C., Bamias A., Fountzilas G., et al. (2010).  A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.. BMC Med. 8, 3.
Fountzilas, G., Dafni U., Dimopoulos M. A., Koutras A., Skarlos D., Papakostas P., et al. (2009).  A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study.. Breast Cancer Res Treat. 115(1), 87-99.
Bamias, A., Karina M., Papakostas P., Kostopoulos I., Bobos M., Vourli G., et al. (2010).  A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer.. Cancer Chemother Pharmacol. 65(6), 1009-21.
Zarogoulidis, K., Mylonaki E., Kakavelas P., Zarogoulidis P., Tsiouda T., Rapti E., et al. (2009).  Topotecan-carboplatin-etoposide combination as 1st line treatment in patients with small cell lung cancer.. Lung Cancer. 66(2), 226-30.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.